Quinazoline derivative having tyrosine kinase inhibitory activity
Details for Australian Patent Application No. 2006216266 (hide)
International Classifications
Event Publications
13 September 2007 PCT application entered the National Phase
PCT publication WO2006/090717 Priority application(s): WO2006/090717
17 January 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 26 Oct 2007
2 April 2009 Corrigenda
Amendments - Amendments Made Under the name Shionogi And Co., Ltd., Application no. 2006216266, under INID(71) amend the name to read Shionogi & Co., Ltd.
18 February 2010 Application Accepted
Published as AU-B-2006216266
6 May 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 15 Apr 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
26 August 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 15 Apr 2010
2 September 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser